Please check your internet connection and try again.
# Sompraz HP (Pantoprazole)
## Overview
Pantoprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion.
## Primary Indications
* Healing of erosive esophagitis associated with gastroesophageal reflux disease (GERD).
* Maintenance of healing of erosive esophagitis.
* Treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
## Adult Dosing
* **Healing of erosive esophagitis:** 40 mg orally once daily for up to 8 weeks.
* **Maintenance of healing:** 40 mg orally once daily.
* **Pathological hypersecretory conditions:** Starting dose is typically 40 mg orally twice daily, but can be increased to 80 mg orally twice daily. Doses may need to be adjusted based on clinical response. Maximum recommended oral dose is 80 mg twice daily.
*Intravenous (IV) Dosing (typically for inpatient use when oral route is not feasible):*
* **Healing of erosive esophagitis and GERD:** 40 mg IV once daily for up to 7 days.
* **Pathological hypersecretory conditions:** 80 mg IV once daily. Doses up to 80 mg IV every 8 hours may be required.
## Pediatric Dosing
Dosing in pediatric patients varies based on age and indication. Consult specific pediatric guidelines.
* **GERD (ages 5 to 16 years):** 15-35 kg: 20 mg orally once daily; >35 kg: 40 mg orally once daily.
* **Erosive esophagitis (ages 5 to 16 years):** 15-35 kg: 20 mg orally once daily for 8 weeks; >35 kg: 40 mg orally once daily for 8 weeks.
## Dose Adjustments
No dose adjustment is typically required for renal impairment. In severe hepatic impairment, a dose of 20 mg orally once daily is recommended.
## Contraindications
* Known hypersensitivity to pantoprazole, any other PPI, or any component of the formulation.
## Adverse Effects
Common adverse effects include headache, diarrhea, nausea, abdominal pain, vomiting, dizziness, and rash. Long-term use may be associated with an increased risk of Clostridium difficile infection, bone fractures (hip, wrist, spine), vitamin B12 deficiency, and hypomagnesemia.
## Key Drug Interactions
* **Clopidogrel:** Pantoprazole may decrease the antiplatelet effect of clopidogrel. Consider alternative PPIs or monitor closely.
* **Methotrexate:** PPIs may increase methotrexate levels.
* **Drugs requiring gastric acid for absorption:** Drugs such as ketoconazole, itraconazole, posaconazole, iron salts, and vitamin B12 absorption may be affected.
## Monitoring
* Monitor for signs and symptoms of hypomagnesemia (e.g., muscle cramps, seizures, tremors, arrhythmias).
* Monitor for signs and symptoms of Clostridium difficile infection.
* Consider monitoring vitamin B12 levels with prolonged therapy.
## Clinical Pearls
* Pantoprazole is typically taken 30-60 minutes before a meal.
* IV administration should be converted to oral as soon as feasible.
* Long-term use of PPIs should be limited to the duration necessary for the condition being treated.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant guidelines for complete and accurate drug information.
